PLAUR and neoplasm: Taken together, to the best of our knowledge, we are the first who have identified Cyr61 and YB-1 as new interaction partners of uPAR and showed that their expression correlated significantly with the expression of tumor-promoting biomarkers and the tumor grade in TNBC specimens.